IP Library Granted Patent US 9,476,088
Granted Patent B2
US 9,476,088 · App. 13/812,122 · Granted Oct 25, 2016

Analyte measurement method and system with hematocrit compensation

Inventors: Adam Craggs (Inverness, GB); Michael Malecha (Muir of Ord, GB); Steve Blythe (Inverness, GB)
Assignee: LifeScan Scotland Limited
C12Q1/54A61B5/1486G01N27/3273
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,476,088
App. No.
13/812,122
Granted
Oct 25, 2016
Kind
B2
Abstract

Described and illustrated herein are systems and exemplary methods of operating an analyte measurement system having a meter and a test strip. In one embodiment, the method may be achieved by applying a first test voltage between a reference electrode and a second working electrode and applying a second test voltage between the reference electrode and a first working electrode; measuring a first test current, a second test current, a third test current and a fourth test current at the second working electrode after a blood sample containing an analyte is applied to the test strip; measuring a fifth test current at the first working electrode; estimating a hematocrit-corrected analyte concentration from the first, second, third, fourth and fifth test currents; and annunciating the hematocrit-corrected analyte concentration.

Claims (283)

1. A method for determining a glucose concentration measurable with a system having a test strip and a meter, the method comprising:

applying a first test voltage between a reference electrode and a second working electrode coated with a reagent layer and applying a second test voltage between a reference electrode and a first working electrode coated with a reagent layer;

measuring a first test current, a second test current, a third test current and a fourth test current at the second working electrode in which blood containing glucose is applied to the test strip to cause a transformation of the glucose in the blood from one form of glucose into another form of glucose and generate a current by an electrochemical re-oxidation of a reduced mediator applied to the test strip;

measuring a fifth test current at the first working electrode;

determining the glucose concentration from the first, second, third, fourth and fifth test currents with an equation of the form:

G

=

(

a

*

I

5

+

b

(

c

*

(

I

2

-

I

1

d

)

+

e

f

*

(

I

2

*

I

1

)

+

g

)

*

(

h

*

(

I

4

-

I

3

k

)

+

p

q

*

(

I

4

*

I

3

)

+

s

)

)

-

intercept

slope

where:

G comprises the glucose concentration;

I 1 comprises the first test current;

I 2 comprises the second test current;

I 3 comprises the third test current;

I 4 comprises the fourth test current;

I 5 comprises the fifth test current;

a, b, c, d, e, f, g, h, k, p, q and s each comprises empirically derived constants;

intercept comprises an intercept value determined from a linear regression of a plot of

a

*

I

5

+

b

(

c

*

(

I

2

-

I

1

d

)

+

e

f

*

(

I

2

*

I

1

)

+

g

)

*

(

h

*

(

I

4

-

I

3

k

)

+

p

q

*

(

I

4

*

I

3

)

+

s

)

 versus a reference glucose concentration; and

slope comprises a slope value determined from a linear regression of a plot of

a

*

I

5

+

b

(

c

*

(

I

2

-

I

1

d

)

+

e

f

*

(

I

2

*

I

1

)

+

g

)

*

(

h

*

(

I

4

-

I

3

k

)

+

p

q

*

(

I

4

*

I

3

)

+

s

)

 versus the reference glucose concentration.

2. The method of claim 1 , in which the reference electrode, the first electrode and the second electrodes are disposed on a single plane.

3. The method of claim 1 , in which the first test current is measured from about 2.18 to about 2.26 seconds after initiation of the measuring.

4. The method of claim 1 , in which the second current is measured from about 2.90 to about 2.98 seconds after initiation of the measuring.

5. The method of claim 1 , in which the third current is measured from about 3.01 to about 3.09 seconds after initiation of the measuring.

6. The method of claim 1 , in which the fourth current is measured from about 0.95 to about 1.03 seconds after initiation of the measuring.

7. The method of claim 1 , in which the fifth current is measured from about 4.74 to about 4.82 seconds after initiation of the measuring.

8. The method of claim 1 , in which a comprises from about 0.0158 to about 0.0162, b comprises from about 3.55 to about 3.59, c comprises from about 24.2 to about 24.6, d comprises from about 71.1 to about 71.5, e comprises from about 6.89 to about 6.93, f comprises from about 0.27 to about 0.31, g comprises from about 81.8 to about 82.2, h comprises from about 102 to about 104, k comprises from about −453 to about −455, p comprises from about −0.0686 to about −0.0690 and q comprises from about 30.2 to about 30.6.

9. The method of claim 1 , in which the slope comprises a value of about minus 0.000545 and the intercept comprises a value of about minus 2.86.

10. A method for determining a hematocrit-corrected test current measurable with a system having a test strip and a meter, the method comprising:

applying a first test voltage between a reference electrode and a second working electrode coated with a reagent layer and applying a second test voltage between a reference electrode and a first working electrode coated with a reagent layer;

measuring a first test current, a second test current, a third test current and a fourth test current at the second working electrode in which blood containing glucose is applied to the test strip to cause a transformation of the glucose in the blood from one form of glucose into another form of glucose and generate a current by an electrochemical re-oxidation of a reduced mediator applied to the test strip;

measuring a fifth test current at the first working electrode; and

determining the hematocrit-corrected test current by determining a ratio of a third corrected current to a first corrected current multiplied by a second corrected current.

11. The method of claim 10 , in which the third corrected current comprises a value determined by an equation of the form:

ic 3= a*I 5 +b

where:

ic3 comprises the third corrected current;

I 5 comprises the fifth test current; and

a and b each comprises an empirically derived constant.

12. The method of claim 10 , in which the first corrected current comprises a value determined by an equation of the form:

ic

1

=

c

*

(

I

2

-

I

1

d

)

+

e

f

*

(

I

2

*

I

1

)

+

g

where:

ic1 comprises the third corrected current;

I 1 comprises the first test current;

I 2 comprises the second test current; and

c, d, e, f and g comprise empirically derived constants.

13. The method of claim 10 , in which the second corrected current comprises a value determined by an equation of the form:

ic

2

=

h

*

(

I

4

-

I

3

k

)

+

p

q

*

(

I

4

*

I

3

)

+

s

where:

ic2 comprises the third corrected current;

I 3 comprises the third test current;

I 4 comprises the fourth test current; and

h, k, p, q and s comprise empirically derived constants.

14. The method of claim 10 , in which the first test current comprises a current measured from about 2.18 to about 2.26 seconds after initiation of the measuring; the second current comprises a current measured from about 2.90 to about 2.98 seconds after initiation of the measuring; the third current comprises a current measured from about 3.01 to about 3.09 seconds after initiation of the measuring; the fourth current comprises a current measured from about 0.95 to about 1.03 seconds after initiation of the measuring; and the fifth current comprises a current measured from about 4.74 to about 4.82 seconds after initiation of the measuring.

Assignments (16)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2026
From: LIFESCAN GLOBAL CORPORATION; LIFESCAN CHINA, LLC; LIFESCAN IP HOLDINGS, LLC
To: LIFESCAN ENTERPRISES LLC
Reel/Frame 075848/0012 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DELETING PROPERTY NUMBER 6990849, 7169116, 7351770, 7462265,7468125, 7572356, 8093903, 8486245, 8066866 AND ADD 10431140 PREVIOUSLY RECORDED AT REEL: 050839 FRAME: 0634. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 12, 2023
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064656/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050840/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN SCOTLAND LTD.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050839/0634 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2013
From: CRAGGS, ADAM; MALECHA, MICHAEL; BLYTHE, STEVE
To: LIFESCAN SCOTLAND LIMITED
Reel/Frame 029689/0888 →
Continuity (2)
Provisional Application 61382234 · Sep 13, 2010
Related Publication 20130199943A1 · Aug 8, 2013